| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5763394 | GENENTECH | Human growth hormone aqueous formulation |
Jun, 2015
(8 years ago) | |
Nutropin Aq Pen is owned by Genentech.
Nutropin Aq Pen contains Somatropin Recombinant.
Nutropin Aq Pen has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Nutropin Aq Pen are:
- US5763394
Nutropin Aq Pen was authorised for market use on 03 January, 2008.
Nutropin Aq Pen is available in injectable;injection dosage forms.
The generics of Nutropin Aq Pen are possible to be released after 09 June, 2015.
Drugs and Companies using SOMATROPIN RECOMBINANT ingredient
Market Authorisation Date: 03 January, 2008
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
NUTROPIN AQ PEN family patents
